Cumberland Pharmaceuticals Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
Cumberland Pharmaceuticals Inc. (CPIX) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of 0.28% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2025-03-07
- Cumberland Pharmaceuticals Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was 0.28%, a 91.57% decline from fiscal 2023.
- Cumberland Pharmaceuticals Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was 3.32%.
- Cumberland Pharmaceuticals Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2022 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 0.28% 10-K · filed 2025-03-07 | |
| 2023-12-31 | 3.32% 10-K · filed 2025-03-07 | -3.32% 10-K · filed 2024-03-13 |
| 2022-12-31 | 0.00% 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |